| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2958.2009.06625.X |
| P8608 | Fatcat ID | release_stvnsuux7ncnhdnml3lak7vazy |
| P932 | PMC publication ID | 4747042 |
| P698 | PubMed publication ID | 19220750 |
| P5875 | ResearchGate publication ID | 229686675 |
| P50 | author | Richard Slayden | Q42718204 |
| Prabagaran Narayanasamy | Q56524450 | ||
| Delphi Chatterjee | Q88537339 | ||
| P2093 | author name string | Anne Lenaerts | |
| Shiva K Angala | |||
| Michio Kurosu | |||
| Dean C Crick | |||
| Sebabrata Mahapatra | |||
| Rakesh K Dhiman | |||
| Melissa E Boyne | |||
| Jerald C Hinshaw | |||
| Kallolmay Biswas | |||
| P2860 | cites work | Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence | Q22122411 |
| Multiple sequence alignment with hierarchical clustering | Q27860956 | ||
| Genes required for mycobacterial growth defined by high density mutagenesis | Q27976512 | ||
| Squalene epoxidase as hypocholesterolemic drug target revisited | Q28216700 | ||
| An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence | Q28378895 | ||
| In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium avium | Q28379222 | ||
| Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis | Q28486418 | ||
| Diarylquinolines target subunit c of mycobacterial ATP synthase | Q28486434 | ||
| Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs | Q28487121 | ||
| Genetic requirements for mycobacterial survival during infection | Q29547599 | ||
| Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program | Q29615311 | ||
| Nonreplicating persistence of mycobacterium tuberculosis | Q29615312 | ||
| A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis | Q29617342 | ||
| Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis. | Q33424477 | ||
| Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication | Q33625169 | ||
| Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models | Q33836720 | ||
| Function of the cytochrome bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption | Q34048408 | ||
| Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration | Q34081424 | ||
| Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates | Q34123800 | ||
| Mycobacterial persistence and immunity | Q34508662 | ||
| Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis | Q34510604 | ||
| The secret lives of the pathogenic mycobacteria | Q35550615 | ||
| M. tuberculosis persistence, latency, and drug tolerance | Q35605917 | ||
| Tuberculosis: a problem with persistence | Q35701685 | ||
| Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis | Q35758962 | ||
| Tuberculosis - metabolism and respiration in the absence of growth | Q35988766 | ||
| Isolation and characterization of isoprene mutants of Escherichia coli | Q36179412 | ||
| Menaquinone biosynthesis in Bacillus subtilis: isolation of men mutants and evidence for clustering of men genes | Q36323128 | ||
| Identification of Bacillus subtilis men mutants which lack O-succinylbenzoyl-coenzyme A synthetase and dihydroxynaphthoate synthase | Q36323139 | ||
| New insights into the function of granulomas in human tuberculosis | Q36346104 | ||
| The molecular phylogeny and systematics of the actinomycetes | Q36677230 | ||
| The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis | Q36954404 | ||
| Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens. | Q36990878 | ||
| Selective killing of nonreplicating mycobacteria | Q39038658 | ||
| The F1Fo-ATP synthase of Mycobacterium smegmatis is essential for growth | Q42234627 | ||
| Quinones as the redox signal for the arc two-component system of bacteria | Q43652042 | ||
| Purification of a cytochrome bc-aa3 supercomplex with quinol oxidase activity from Corynebacterium glutamicum. Identification of a fourth subunity of cytochrome aa3 oxidase and mutational analysis of diheme cytochrome c1. | Q44226069 | ||
| Modeling the E. coli 4-hydroxybenzoic acid oligoprenyltransferase ( ubiA transferase) and characterization of potential active sites | Q45186078 | ||
| Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis | Q46484820 | ||
| The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action | Q47215316 | ||
| Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin. | Q48751558 | ||
| Ubiquinone and menaquinone in bacteria: a comparative study of some bacterial respiratory systems | Q68563296 | ||
| The latent tuberculosis bacillus (I'll let you know if I ever meet one) | Q74253950 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 85-97 | |
| P577 | publication date | 2009-02-11 | |
| P1433 | published in | Molecular Microbiology | Q6895967 |
| P1476 | title | Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence | |
| P478 | volume | 72 |
| Q61799106 | 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain |
| Q42183084 | 5'-methylthioadenosine nucleosidase is implicated in playing a key role in a modified futalosine pathway for menaquinone biosynthesis in Campylobacter jejuni |
| Q37644488 | A Novel Small-Molecule Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister Cells |
| Q42950434 | A stable analog of isochorismate for the study of MenD and other isochorismate-utilizing enzymes |
| Q40816049 | Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis |
| Q33831478 | Accumulation of heptaprenyl diphosphate sensitizes Bacillus subtilis to bacitracin: implications for the mechanism of resistance mediated by the BceAB transporter |
| Q37257062 | Adenylating enzymes in Mycobacterium tuberculosis as drug targets |
| Q37112508 | Advances in MRSA drug discovery: where are we and where do we need to be? |
| Q89581361 | Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogen Mycobacterium tuberculosis |
| Q27658311 | Biochemical and structural characterization of CYP124: A methyl-branched lipid -hydroxylase from Mycobacterium tuberculosis |
| Q52688603 | Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery. |
| Q40416869 | Biosynthesis and Regulation of Sulfomenaquinone, a Metabolite Associated with Virulence in Mycobacterium tuberculosis |
| Q37014008 | Bringing Bioactive Compounds into Membranes: The UbiA Superfamily of Intramembrane Aromatic Prenyltransferases |
| Q64052652 | Characterization of MenA (isoprenyl diphosphate:1,4-dihydroxy-2-naphthoate isoprenyltransferase) from Mycobacterium tuberculosis |
| Q40450063 | CoA Adducts of 4-Oxo-4-Phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis Menaquinone Biosynthesis Pathway. |
| Q48023894 | Crystal structure of the thioesterification conformation of Bacillus subtilis o-succinylbenzoyl-CoA synthetase reveals a distinct substrate-binding mode. |
| Q21133565 | Crystal structures of E. coli native MenH and two active site mutants |
| Q60949745 | Demethylmenaquinone Methyl Transferase Is a Membrane Domain-Associated Protein Essential for Menaquinone Homeostasis in |
| Q38928537 | Discovery of bicyclic inhibitors against menaquinone biosynthesis. |
| Q36032548 | Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis |
| Q28486525 | DosS responds to a reduced electron transport system to induce the Mycobacterium tuberculosis DosR regulon |
| Q49968014 | Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality? |
| Q33820093 | Electron Transport Chain Is Biochemically Linked to Pilus Assembly Required for Polymicrobial Interactions and Biofilm Formation in the Gram-Positive Actinobacterium Actinomyces oris |
| Q34383371 | Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria. |
| Q37712986 | Energy metabolism and drug efflux in Mycobacterium tuberculosis |
| Q35961401 | Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis |
| Q34285993 | Gene expression profiling of Mycobacterium avium subsp. paratuberculosis in simulated multi-stress conditions and within THP-1 cells reveals a new kind of interactive intramacrophage behaviour. |
| Q35795582 | Genetic Approaches to Facilitate Antibacterial Drug Development |
| Q34628570 | Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids |
| Q41336359 | Genome-based exploration of the specialized metabolic capacities of the genus Rhodococcus |
| Q34337730 | Identification of a hotdog fold thioesterase involved in the biosynthesis of menaquinone in Escherichia coli |
| Q28833704 | Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars |
| Q36668462 | Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone |
| Q34297816 | Latent tuberculosis infection: myths, models, and molecular mechanisms |
| Q27696145 | Ligand-dependent active-site closure revealed in the crystal structure of Mycobacterium tuberculosis MenB complexed with product analogues |
| Q36219822 | Mechanism of MenE inhibition by acyl-adenylate analogues and discovery of novel antibacterial agents |
| Q89563717 | Metabolic profiling of dormant Mycolicibacterium smegmatis cells' reactivation reveals a gradual assembly of metabolic processes |
| Q64951992 | Metabolite Profiling: A Tool for the Biochemical Characterisation of Mycobacterium sp. |
| Q33688223 | Methods for Structural and Functional Analyses of Intramembrane Prenyltransferases in the UbiA Superfamily |
| Q35859964 | Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis |
| Q33854785 | Multitarget drug discovery for tuberculosis and other infectious diseases |
| Q36500349 | Mycobacterium Lysine ε-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level. |
| Q35868335 | Mycoketide: a CD1c-presented antigen with important implications in mycobacterial infection |
| Q36153263 | New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development. |
| Q34596427 | Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis |
| Q39029684 | Novel long-chain compounds with both immunomodulatory and MenA inhibitory activities against Staphylococcus aureus and its biofilm. |
| Q38672958 | Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions |
| Q28487581 | Partial Saturation of Menaquinone in Mycobacterium tuberculosis: Function and Essentiality of a Novel Reductase, MenJ |
| Q55196512 | Phylogeny Trumps Chemotaxonomy: A Case Study Involving Turicella otitidis. |
| Q33715815 | Primary transcriptomes of Mycobacterium avium subsp. paratuberculosis reveal proprietary pathways in tissue and macrophages |
| Q54203363 | RepTB: a gene ontology based drug repurposing approach for tuberculosis. |
| Q90538966 | Self-control of vitamin K2 production captured in the crystal |
| Q62649637 | Structure-Based Design, Synthesis, and Biological Evaluation of Non-Acyl Sulfamate Inhibitors of the Adenylate-Forming Enzyme MenE |
| Q36393640 | Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections |
| Q37990720 | Targeting persisters for tuberculosis control |
| Q37679327 | The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition |
| Q36963920 | The membrane as a target for controlling hypervirulent Clostridium difficile infections |
| Q34355375 | The mycobacterial cell envelope-lipids |
| Q35664209 | The tuberculosis drug discovery and development pipeline and emerging drug targets |
| Q38219605 | Tuberculosis drug discovery and emerging targets |
| Q37718564 | Vitamin K2 in electron transport system: are enzymes involved in vitamin K2 biosynthesis promising drug targets? |
Search more.